The acquisition contributed to 3.1 percent worldwide operational sales growth on the full year. Johnson & Johnson’s orthopedics business experienced 60.8 percent sales growth during the fourth quarter and 34 percent sales growth over the entire year in the United States. Worldwide, the company’s orthopedics business saw a 64.3 percent sales growth to $2.3 billion in the fourth quarter and 34.3 percent sales growth over the full year to $7.7 billion.
More Articles on Orthopedic Device:
Implant Device Market to Reach $73.9B Value in 2018
6 Potential Effects of the Medical Device Tax on Orthopedics Companies
Zimmer Introduces Its 1st Lateral Plate System for Spinal Trauma
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
